NexImmune Inc Ordinary Shares NEXI
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–2.17
- Bid/Ask
- $0.03 / $0.15
- Shares Outstanding
- 1.39M
- Market Cap
- $139.47
- Volume/Avg
- 514 / 665
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 50
- Website
- https://www.neximmune.com
Valuation
|
Metric
|
NEXI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NEXI
|
|---|---|
Quick Ratio | 0.51 |
Current Ratio | 0.66 |
Interest Coverage | — |
Quick Ratio
NEXI
Profitability
|
Metric
|
NEXI
|
|---|---|
Return on Assets (Normalized) | −130.58% |
Return on Equity (Normalized) | −249.29% |
Return on Invested Capital (Normalized) | −239.23% |
Return on Assets
NEXI
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|yG!??X | LOCK|TV?Yn | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|K!W$@P | LOCK|<@!W | $83B | |||
| Moderna Inc
MRNA
| LOCK|$$%J@? | LOCK|V<z | $80B | |||
| argenx SE ADR
ARGX
| LOCK|H>%q$< | LOCK|K$ | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|PX@!$BN | LOCK|!C! | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|qVS$Cj | LOCK|dq>$ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|w#!wpZ>& | LOCK|%SQs | $28B | |||
| Incyte Corp
INCY
| LOCK|G<!Hrc@ | LOCK|%Fq | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|@%#!q!H | LOCK|J& | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|<lXzKfP | LOCK|xb | $14B |
United States